Inventiva Revenue vs. Shares Owned By Institutions
IVA Stock | EUR 2.46 0.04 1.65% |
For Inventiva profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Inventiva to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Inventiva SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Inventiva's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Inventiva SA over time as well as its relative position and ranking within its peers.
Inventiva |
Inventiva SA Shares Owned By Institutions vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Inventiva's current stock value. Our valuation model uses many indicators to compare Inventiva value to that of its competitors to determine the firm's financial worth. Inventiva SA is considered the number one company in revenue category among its peers. It also is currently regarded as number one stock in shares owned by institutions category among its peers . The ratio of Revenue to Shares Owned By Institutions for Inventiva SA is about 88,724 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Inventiva by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Inventiva's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Inventiva Revenue vs. Competition
Inventiva SA is considered the number one company in revenue category among its peers. Market size based on revenue of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 569.78 Million. Inventiva maintains roughly 4.19 Million in revenue contributing less than 1% to equities under Drug Manufacturers - Specialty & Generic industry.
Inventiva Shares Owned By Institutions vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Inventiva |
| = | 4.19 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Inventiva |
| = | 47.27 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Inventiva Shares Owned By Institutions Comparison
Inventiva is currently under evaluation in shares owned by institutions category among its peers.
Inventiva Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Inventiva, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Inventiva will eventually generate negative long term returns. The profitability progress is the general direction of Inventiva's change in net profit over the period of time. It can combine multiple indicators of Inventiva, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Inventiva S.A., a biopharmaceutical company, develops drugs for the treatment of fibrotic, cancer, and orphan diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. INVENTIVA is traded on Paris Stock Exchange in France.
Inventiva Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Inventiva. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Inventiva position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Inventiva's important profitability drivers and their relationship over time.
Use Inventiva in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inventiva position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will appreciate offsetting losses from the drop in the long position's value.Inventiva Pair Trading
Inventiva SA Pair Trading Analysis
The ability to find closely correlated positions to Inventiva could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inventiva when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inventiva - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inventiva SA to buy it.
The correlation of Inventiva is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inventiva moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inventiva SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inventiva can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Inventiva position
In addition to having Inventiva in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run High Yield ETFs Thematic Idea Now
High Yield ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Yield ETFs theme has 105 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Yield ETFs Theme or any other thematic opportunities.
View All Next | Launch |
Additional Information and Resources on Investing in Inventiva Stock
When determining whether Inventiva SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inventiva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inventiva Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inventiva Sa Stock:Check out Risk vs Return Analysis. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
To fully project Inventiva's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Inventiva SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Inventiva's income statement, its balance sheet, and the statement of cash flows.